STAMFORD, Conn., Nov. 03, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether Selecta’s board of directors (the “Board”) has violated its fiduciary duty by instituting measures intended to interfere with the ability of Selecta stockholders to elect directors of their choosing.
Selecta stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
Helicopter will be onsite for racers and crew members needing emergency air transport Life Saver…
A Leader of Technology-Enabled Water Solutions Has Welcomed Three Companies This YearST. LOUIS, April 21, 2025…
ST. PETERSBURG, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- With Earth Day on the horizon,…
DigitCells, an innovator at the forefront of comprehensive pathology solutions, and Mindpeak, a pioneering force…
GUELPH, Ontario, April 21, 2025 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS” or the…
ThriftBooks Expands BuyBack Program to Serve Bulk Booksellers Nationwide ThriftBooks Logo three teal books above…
This website uses cookies.